Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Post-acute COVID-19 syndrome, SARS-CoV-2 test, Vaccination failure
Clinical narrative: Patient got post COVID syndrome; VACCINATION FAILURE; Patient got COVID-19; This spontaneous case was reported by an other health care professional and describes the occurrence of COVID-19 (Patient got COVID-19), POST-ACUTE COVID-19 SYNDROME (Patient got post COVID syndrome) and VACCINATION FAILURE (VACCINATION FAILURE) in a 59-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 067H21A and 067F21A) for COVID-19 vaccination.     No other vaccines were given within 1 month prior to Moderna COVID-19 vaccine.  Concurrent medical conditions included Seasonal allergy, Hypothyroidism (Recent change in status such as improvement or worsening: unknown), Dyslipidemia (Recent change in status such as improvement or worsening: unknown), Hypertension (Recent change in status such as improvement or worsening: unknown), Obstructive sleep apnea hypopnea syndrome (Recent change in status such as improvement or worsening: unknown), Left ventricular hypertrophy (Recent change in status such as improvement or worsening: unknown), Gastroesophageal reflux (Recent change in status such as improvement or worsening: unknown), Tachycardia (Recent change in status such as improvement or worsening: unknown) and Morbid obesity (Recent change in status such as improvement or worsening: unknown). Concomitant products included LEVOTHYROXINE, TIRZEPATIDE (MOUNJARO), DESVENLAFAXINE SUCCINATE MONOHYDRATE (PRISTIQ), MONTELUKAST SODIUM (SINGULAIR), CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]), OMEPRAZOLE (PRILOSEC [OMEPRAZOLE]), METOPROLOL TARTRATE and ONDANSETRON (ZOFRAN [ONDANSETRON]) for an unknown indication.   On 19-Nov-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Dec-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In June 2022, the patient experienced COVID-19 (Patient got COVID-19) and VACCINATION FAILURE (VACCINATION FAILURE). On an unknown date, the patient experienced POST-ACUTE COVID-19 SYNDROME (Patient got post COVID syndrome). At the time of the report, COVID-19 (Patient got COVID-19), POST-ACUTE COVID-19 SYNDROME (Patient got post COVID syndrome) and VACCINATION FAILURE (VACCINATION FAILURE) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In June 2022, SARS-CoV-2 test: Positive.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No treatment medications were reported.  Company comment: This spontaneous case reported by other health care professional, concerns a 59-year-old, female subject with relevant medical history of morbid obesity, obstructive sleep apnea syndrome, who experienced the unexpected non-serious event of COVID 19. The event occurred approximately 7 months after the first dose of mRNA-1273 vaccine and approximately 6 months after the second dose of mRNA-1273 vaccine. Primary vaccination series was administered in an appropriate schedule, hence vaccination failure was considered as an additional event. SARS-CoV-2 test was positive. The outcome of the event COVID 19 was unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   This case was linked to MOD-2022-670564 (Patient Link).; Sender's Comments: This spontaneous case reported by other health care professional, concerns a 59-year-old, female subject with relevant medical history of morbid obesity, obstructive sleep apnea syndrome, who experienced the unexpected non-serious event of COVID 19. The event occurred approximately 7 months after the first dose of mRNA-1273 vaccine and approximately 6 months after the second dose of mRNA-1273 vaccine. Primary vaccination series was administered in an appropriate schedule, hence vaccination failure was considered as an additional event. SARS-CoV-2 test was positive. The outcome of the event COVID 19 was unknown. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.